These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2364092)

  • 1. Conformational dynamics in fluorophenylcarbamoyl-alpha-chymotrypsins.
    Kairi M; Gerig JT
    Biochim Biophys Acta; 1990 Jun; 1039(2):157-70. PubMed ID: 2364092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of alpha-chymotrypsin-N-trifluoroacetyl-4-fluorophenylalanine complexes.
    Jacobson AR; Gerig JT
    J Biomol NMR; 1991 Jul; 1(2):131-44. PubMed ID: 1841692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformations of N-(2-fluorophenyl)-N-phenylcarbamoyl-alpha-chymotrypsin.
    Kairi M; Keder NL; Gerig JT
    Arch Biochem Biophys; 1990 Jun; 279(2):305-14. PubMed ID: 2350178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motion at the active site of [(4-fluorophenyl)sulfonyl]chymotrypsin.
    Ando ME; Gerig JT; Luk KF
    Biochemistry; 1986 Aug; 25(17):4772-8. PubMed ID: 3768312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR studies of the alpha-chymotrypsin-(R)-1-acetamido-2-(4- fluorophenyl)ethane-1-boronic acid complex.
    Sylvia LA; Gerig JT
    Biochim Biophys Acta; 1993 Jun; 1163(3):321-34. PubMed ID: 8507671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncovalent inhibition of the serine proteases, alpha-chymotrypsin and trypsin by trifluoro(organo)borates.
    Smoum R; Rubinstein A; Srebnik M
    Org Biomol Chem; 2005 Mar; 3(5):941-4. PubMed ID: 15731882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of 19F labeled sulfonyl fluorides as probes of protease structure: alpha-chymotrypsin.
    Tsunematsu H; Nishikawa H; Berliner LJ
    J Biochem; 1984 Aug; 96(2):349-55. PubMed ID: 6501246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton and fluorine nuclear magnetic resonance spectroscopic observation of hemiacetal formation between N-acyl-p-fluorophenylalaninals and alpha-chymotrypsin.
    Gorenstein DG; Shah DO
    Biochemistry; 1982 Sep; 21(19):4679-86. PubMed ID: 7138821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for hemiacetal formation between N-acyl-L-phenylalaninals and alpha-chymotrypsin by cross-saturation nuclear magnetic resonance spectroscopy.
    Chen R; Gorenstein DG; Kennedy WP; Lowe G; Nurse D; Schultz RM
    Biochemistry; 1979 Mar; 18(5):921-6. PubMed ID: 420824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine magnetic resonance studies of fluorine-substituted benzoyl chymotrypsins.
    Amshey JW; Bender ML
    Arch Biochem Biophys; 1983 Jul; 224(1):378-81. PubMed ID: 6870262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spin-labeled sulfonyl fluorides as active site probes of protease structure. I. Comparison of the active site environments in alpha-chymotrypsin and trypsin.
    Berliner LJ; Wong SS
    J Biol Chem; 1974 Mar; 249(6):1668-77. PubMed ID: 4361818
    [No Abstract]   [Full Text] [Related]  

  • 12. NMR studies of the alpha-chymotrypsin-(R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid complex at pH 7.
    Sylvia LA; Gerig JT
    Biochim Biophys Acta; 1995 Oct; 1252(2):225-32. PubMed ID: 7578227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
    Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
    J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis, kinetic characterization and application of biotinylated aminoacylchloromethanes for the detection of chymotrypsin and trypsin-like serine proteinases.
    Kay G; Bailie JR; Halliday IM; Nelson J; Walker B
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):455-9. PubMed ID: 1575691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton chemical shifts in fluorocinnamate-chymotrypsin complexes.
    Gerig JT; Halley BA
    Arch Biochem Biophys; 1984 Aug; 232(2):467-76. PubMed ID: 6087727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deactivation of alpha-chymotrypsin and alpha-chymotrypsin-CNBr-Sepharose 4B conjugates in aliphatic alcohols.
    Clark DS; Bailey JE
    Biochim Biophys Acta; 1984 Jul; 788(2):181-8. PubMed ID: 6743665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability studies of oxazolidine-based compounds using 1H NMR spectroscopy.
    Moloney GP; Iskander MN; Craik DJ
    J Pharm Sci; 2010 Aug; 99(8):3362-71. PubMed ID: 20229599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors.
    Łegowska A; Debowski D; Lesner A; Wysocka M; Rolka K
    Bioorg Med Chem; 2009 May; 17(9):3302-7. PubMed ID: 19362846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic study of alpha-chymotrypsin catalysis with regard to the interaction between the specificity-determining site and the aromatic side chain of substrates.
    Ohno M; Sato S; Karasaki Y; Tsukamoto S
    J Biochem; 1976 Aug; 80(2):239-51. PubMed ID: 1002668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the interaction of 4-bromomercuriocinnamic acid with alpha-chymotrypsin by 79 Br and 81Br pulsed nuclear-magnetic resonance.
    Garnett MW; Halstead TK; Hoare DG
    Eur J Biochem; 1976 Jun; 66(1):85-93. PubMed ID: 954747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.